SUMATRIPTAN SUCCINATE Drug Patent Profile
✉ Email this page to a colleague
When do Sumatriptan Succinate patents expire, and what generic alternatives are available?
Sumatriptan Succinate is a drug marketed by Antares Pharma Inc, Baxter Hlthcare Corp, Caplin, Dr Reddys, Endo Operations, Eugia Pharma, Fresenius Kabi Usa, Hikma, Norvium Bioscience, Sandoz, Steriscience Speclts, Sun Pharm, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Zydus, Aurobindo Pharma, Corepharma, Dr Reddys Labs Inc, Fosun Pharma, Hikma Pharms, Mylan, Orbion Pharms, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirty-four NDAs.
The generic ingredient in SUMATRIPTAN SUCCINATE is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sumatriptan Succinate
A generic version of SUMATRIPTAN SUCCINATE was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUMATRIPTAN SUCCINATE?
- What are the global sales for SUMATRIPTAN SUCCINATE?
- What is Average Wholesale Price for SUMATRIPTAN SUCCINATE?
Summary for SUMATRIPTAN SUCCINATE
| US Patents: | 0 |
| Applicants: | 29 |
| NDAs: | 34 |
| Finished Product Suppliers / Packagers: | 30 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 26 |
| Patent Applications: | 2,223 |
| Drug Prices: | Drug price information for SUMATRIPTAN SUCCINATE |
| What excipients (inactive ingredients) are in SUMATRIPTAN SUCCINATE? | SUMATRIPTAN SUCCINATE excipients list |
| DailyMed Link: | SUMATRIPTAN SUCCINATE at DailyMed |
See drug prices for SUMATRIPTAN SUCCINATE
Recent Clinical Trials for SUMATRIPTAN SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Affiliated Hospital of Qingdao University | Phase 3 |
| Jiangsu Provincial People's Hospital | Phase 3 |
| West China Hospital | Phase 3 |
Pharmacology for SUMATRIPTAN SUCCINATE
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for SUMATRIPTAN SUCCINATE
US Patents and Regulatory Information for SUMATRIPTAN SUCCINATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 077744-001 | Aug 10, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys Labs Inc | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 076847-002 | Aug 10, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Roxane | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 078241-001 | Aug 10, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 076840-003 | Feb 9, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 077744-003 | Aug 10, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Roxane | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 078241-002 | Aug 10, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
